Researchers who spoke to Nature say they don’t have the money or staff to do fieldwork or process samples.

Study finds dozens of journals that have hiked their fees and started churning out papers after being acquired by small, recently formed companies.

Bold claims of ‘biosignature’ molecules trigger an outpouring of scepticism.

The National Science Foundation is the latest US agency to be disrupted by Elon Musk’s DOGE.

Understanding the playbook that those in power use to twist numbers, and how they make others complicit, is only becoming more important in the post-truth world.

Potato ‘pangenome’ could allow easier sequencing of new varieties — plus, a Nature analysis reveals the most cited paper written in the twenty-first century.

Neutron-scattering experiments have revealed a predicted high-pressure phase of ice called ‘plastic ice VII’, in which molecules form crystals, as they do in normal ice, but rotate as in liquid water. These data highlight the role of hydrogen dynamics in defining exotic ice phases and could have implications for the geodynamics of icy planets.

A method for examining RNAs in blood samples offers a clinical tool to detect and monitor cancer and to assess immune responses to vaccination.

Metformin could reduce people’s risk of certain age-associated blood cancers, but more work is needed to identify who is likely to benefit.

Transplanting dopamine-releasing neurons into the brain is a promising regenerative therapy for Parkinson’s disease. Two clinical trials show that it is safe, but more evidence is needed to prove its effectiveness.

Potential treatments need to be subject to the highest standards of safety and efficacy.

Studies show the therapy is safe, but bigger trials are needed to prove its efficacy.

Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might be around the corner.

The World Health Organization accord promotes sharing scientific data in exchange for more equitable distribution of drugs and vaccines.

Inked scientists choose scientific images to mark career accomplishments and illustrate their research passion.

Fatal blood clots can arise in people who have cancer. The discovery of a cue that underlies these clots offers a therapeutic target and a way to assess clot risk.